FAKTOR-OPTIONSSCHEIN - INMODE Stock

Certificat

DE000ME922X8

Delayed Börse Stuttgart 09:23:18 2024-06-06 EDT
0.33 EUR 0.00% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
Current month-13.16%
1 month+3.12%
Date Price Change
24-06-06 0.33 0.00%
24-06-05 0.33 -10.81%
24-06-04 0.37 -5.13%
24-06-03 0.39 +2.63%
24-05-31 0.38 +5.56%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 09:23 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN ME922X
ISINDE000ME922X8
Date issued 2024-02-21
Strike 16.39 $
Maturity Unlimited
Parity 6.26 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.28
Lowest since issue 0.249

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.73 USD
Average target price
25.6 USD
Spread / Average Target
+36.68%
Consensus